Our firm represents many of the world’s leading pharmaceutical, biotechnology, medical device, and other life sciences companies in their most significant mass tort and product liability litigation.
Our lawyers have decades of experience litigating these cases. We know how to strategically organize complex cases to win. We have enjoyed great victories framing scientific issues and positioning cases successfully for Daubert and analogous state-court challenges, often leading to summary judgment of hundreds of cases in favor of our clients. Our lawyers have also won landmark cases in state and federal appellate courts—including the United States Supreme Court—on significant class action and tort law issues.
Our practice and our attorneys are recognized as the best in the field. Named “Product Liability Group of the Year” for 2017 by Law360, we were also shortlisted for the 2014, 2015, 2016 “Chambers USA Awards for Excellence” and twice named, in 2014 and 2015, “Product Liability Practice Group of the Year” by Chambers USA.. Our team of over 50 lawyers has been involved in some of the most significant complex tort litigations of the last 30 years, including product liability litigation involving Zoloft® and Lipitor®, and we are at the forefront of the opioid litigations. Our attorneys have also been individually recognized as outstanding by publications such as Chambers USA, The National Law Journal, Law360, The International Who’s Who of Product Liability Defence Lawyers, The Best Lawyers in America, Fortune, and Crain’s New York Business, and Legal 500.
Our practice has been recognized as the best in the field. Below are some of our recent accolades:
Notable Recent Wins
Landmark Mass Tort Rulings